Pyrazolo[4,3-d][1,3]benzodiazepine, 5-(2,6-difluorophenyl)-9-fluoro-2,4-dihydro-8-(4-pyridazinyl)-

Pyrazolo[4,3-d][1,3]benzodiazepine, 5-(2,6-difluorophenyl)-9-fluoro-2,4-dihydro-8-(4-pyridazinyl)- Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +17819995354
Email: marketing@targetmol.com
Products Intro: Product Name:LRRK2/NUAK1/TYK2-IN-1
CAS:2629192-96-5
Package:25mg;1520USD|50mg;1980USD|100mg;2500USD
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Products Intro: Product Name:LRRK2/NUAK1/TYK2-IN-1
CAS:2629192-96-5
Package:25mg/RMB 10600;50mg/RMB 13800;100mg/RMB 17500

Pyrazolo[4,3-d][1,3]benzodiazepine, 5-(2,6-difluorophenyl)-9-fluoro-2,4-dihydro-8-(4-pyridazinyl)- manufacturers

Pyrazolo[4,3-d][1,3]benzodiazepine, 5-(2,6-difluorophenyl)-9-fluoro-2,4-dihydro-8-(4-pyridazinyl)- Basic information
Product Name:Pyrazolo[4,3-d][1,3]benzodiazepine, 5-(2,6-difluorophenyl)-9-fluoro-2,4-dihydro-8-(4-pyridazinyl)-
Synonyms:Pyrazolo[4,3-d][1,3]benzodiazepine, 5-(2,6-difluorophenyl)-9-fluoro-2,4-dihydro-8-(4-pyridazinyl)-;5-(2,6-Difluorophenyl)-9-fluoro-8-(pyridazin-4-yl)-2,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine;LRRK2/NUAK1/TYK2-IN-1
CAS:2629192-96-5
MF:C20H11F3N6
MW:392.34
EINECS:
Product Categories:
Mol File:2629192-96-5.mol
Pyrazolo[4,3-d][1,3]benzodiazepine, 5-(2,6-difluorophenyl)-9-fluoro-2,4-dihydro-8-(4-pyridazinyl)- Structure
Pyrazolo[4,3-d][1,3]benzodiazepine, 5-(2,6-difluorophenyl)-9-fluoro-2,4-dihydro-8-(4-pyridazinyl)- Chemical Properties
Boiling point 744.9±60.0 °C(Predicted)
density 1.57±0.1 g/cm3(Predicted)
pka12.95±0.20(Predicted)
Safety Information
MSDS Information
Pyrazolo[4,3-d][1,3]benzodiazepine, 5-(2,6-difluorophenyl)-9-fluoro-2,4-dihydro-8-(4-pyridazinyl)- Usage And Synthesis
UsesLRRK2/NUAK1/TYK2-IN-1 (conpound 226) shows inhibitory activity toward LRRK2 (Wt), LRRK2 (G2019), TYK2 and NUAK1, with IC50 values lower than 10 nM. LRRK2/NUAK1/TYK2-IN-1 can be used for autoimmune disease research[1].
IC 50Tyk2; NUAK1
References[1] Roland Koestler, et al. 1,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine derivatives and related compounds as lrrk2, nuak1 and/or tyk2 kinase modulators for the treatment of e.g. autoimmune disease. Patent WO2021048618A1.
Pyrazolo[4,3-d][1,3]benzodiazepine, 5-(2,6-difluorophenyl)-9-fluoro-2,4-dihydro-8-(4-pyridazinyl)- Preparation Products And Raw materials
Tag:Pyrazolo[4,3-d][1,3]benzodiazepine, 5-(2,6-difluorophenyl)-9-fluoro-2,4-dihydro-8-(4-pyridazinyl)-(2629192-96-5) Related Product Information

  • HomePage | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms | About Us
  • All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
    According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.
  • Copyright © 2023 ChemicalBook All rights reserved.